REQUEST A DEMO
Total
USD $0.00
Search more companies

Deepnoid Inc. (South Korea)

Main Activities: Software Publishers
Full name: Deepnoid Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company principally engaged in the medical artificial intelligence (AI) solutions. The Company a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The Company was established on February 4, 2008. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on August 17, 2021.

Headquarters
1305, 13F, Enc Venture Dream Tower, 2 Cha, 55, Digital-Ro 33-Gil, Guro-Gu
Seoul; Seoul;

Contact Details: Purchase the Deepnoid Inc. report to view the information.

Website: http://www.deepnoid.com

Basic Information
Total Employees:
Purchase the Deepnoid Inc. report to view the information.
Outstanding Shares:
Purchase the Deepnoid Inc. report to view the information.
Registered Capital:
Purchase the Deepnoid Inc. report to view the information.
Financial Auditors:
Purchase the Deepnoid Inc. report to view the information.
Incorporation Date:
February 04, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜딥노이드
Company Performance
Financial values in the chart are available after Deepnoid Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-39.24%
Total operating revenue
-40.99%
Operating profit (EBIT)
-10.95%
EBITDA
-11.27%
Net Profit (Loss) for the Period
-26.3%
Total assets
136.96%
Total equity
172.7%
Operating Profit Margin (ROS)
-157.26%
Net Profit Margin
-180.87%
Return on Equity (ROE)
28.73%
Debt to Equity Ratio
-6.31%
Quick Ratio
1.83%
Cash Ratio
1.19%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?